Nyhetsrum - PILA PHARMA | beQuoted Nyheter

Pressmeddelanden

2026-03-19 17:00

PILA PHARMA CLARIFIES: DECISION TO POSTPONE THE ANNUAL REPORT TO AWAIT CONCLUSION ON PRECLINICAL OBESITY STUDIES PILA PHARMA AB (publ) ("PILA PHARMA" or the "Company") yesterday announced that the publication of the annual report for the 2025 fiscal year and the date for the annual general...

2026-03-18 18:15

REG

PILA PHARMA POSTPONES THE PUBLICATION OF THE ANNUAL REPORT AND THE ANNUAL GENERAL MEETING PILA PHARMA AB (publ) ("PILA PHARMA" or the "Company") announces that the publication of the annual report for the 2025 fiscal year will be postponed. The annual report is at an...

2026-03-05 16:15

PILA PHARMA: TO PARTICIPATE IN PHARMA PARTNERSHIP CONFERENCE BIO EUROPE SPRING IN LISBON, MARCH 23-25 PILA PHARMA AB (publ) (FN STO: PILA) ("PILA" or the "Company"), an innovative biotech company developing a novel oral drug based on TRPV1 inhibition, today shares its participati...

2026-03-05 15:30

PILA PHARMA: TO2 WARRANTS CONVERTED, SHARES ARE NOW TRADABLE - CEO & FOUNDER'S PARTICIPATION DISCLOSED PILA PHARMA AB (publ) (FN STO: PILA) ("PILA" or "the Company"), an innovative biotech company developing novel oral drugs based on TRPV1 inhibition, informs of the conversion of...

2026-02-17 16:00

PILA PHARMA: MANAGEMENT TEAM COMMENTS ON OUTCOME OF TO2 WARRANTS PILA PHARMA AB (publ) (FN STO: PILA), an innovative biotech company developing novel oral drugs based on TRPV1 inhibition, today announced the outcome of exercise in warrants of...

2026-02-17 12:00

REG MAR

PILA PHARMA ANNOUNCES THE OUTCOME IN THE EXERCISE OF WARRANTS OF SERIES TO2 THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEA...

Visa fler pressmeddelanden